Giles Wilson Acquires 222 Shares of Dr. Martens plc (LON:DOCS) Stock

Dr. Martens plc (LON:DOCS) insider Giles Wilson bought 222 shares of the company’s stock in a transaction that occurred on Monday, January 13th. The shares were acquired at an average price of GBX 68 ($0.83) per share, for a total transaction of £150.96 ($184.71).

Giles Wilson also recently made the following trade(s):

• On Monday, November 11th, Giles Wilson purchased 263 shares of Dr. Martens stock. The stock was acquired at an average price of GBX 57 ($0.70) per share, with a total value of £149.91 ($183.42).

Dr. Martens Price Performance

Shares of DOCS stock opened at GBX 68.29 ($0.84) on Friday. Dr. Martens plc has a fifty-two week low of GBX 49.32 ($0.60) and a fifty-two week high of GBX 100 ($1.22). The company has a debt-to-equity ratio of 129.55, a quick ratio of 1.13 and a current ratio of 2.85. The firm has a market capitalization of £656.78 million, a price-to-earnings ratio of 975.60, a PEG ratio of 6.40 and a beta of 0.11. The stock’s 50-day simple moving average is GBX 67.58 and its 200-day simple moving average is GBX 65.78.

Dr. Martens Cuts Dividend

The business also recently declared a dividend, which will be paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th will be paid a dividend of GBX 0.85 ($0.01) per share. The ex-dividend date of this dividend is Thursday, March 6th. This represents a yield of 1.47%. Dr. Martens’s payout ratio is 4,285.71%.

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.